Our Recommendations
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic) (2022)
- Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
New Publications
- Therapeutics and COVID-19 (Living Guideline, 10 November 2023) (2023)
- Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia Region to support universal health coverage (2023)
- Clinical management of COVID-19: Living guideline, 18 August 2023 (2023)
- Drugs to prevent COVID-19: living guideline (2023)
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
Filter
550
Featured
Recommendations
140
New Publications
3
Language
Document type
Guidelines
283
Fact sheets
90
Studies & Reports
55
Manuals
41
Infographics
22
Videos
14
Resource Platforms
13
Online Courses
13
Training Material
10
Situation Updates
5
Brochures
2
No document type
2
Countries / Regions
Russia
50
Brazil
44
Germany
29
Latin America and the Carribbean
27
Middle East and North Africa
22
Mozambique
21
West and Central Africa
21
Angola
21
Guinea-Bissau
16
East and Southern Africa
16
Africa
13
Global
11
Syria
10
Eastern Europe and Central Asia
10
Yemen
10
Spain
9
South Africa
7
Western and Central Europe
5
Eastern Europe
5
Ecuador
5
India
4
Western Pacific Region
3
France
3
Argentina
3
Vietnam
3
South Sudan
3
Ukraine
2
Kazakhstan
2
Nigeria
2
Philippines
2
Haiti
2
South–East Asia Region
2
Portugal
2
Sudan
2
Nepal
1
Switzerland
1
El Salvador
1
Turkey
1
Benin
1
Togo
1
China
1
Cameroon
1
Canada
1
Laos
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Burkina Faso
1
Burundi
1
Austria
1
Italy
1
Cambodia
1
Venezuela
1
Saudi Arabia
1
Luxembourg
1
Belgium
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Djibouti
1
Central African Republic
1
Ethiopia
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
224
Clinical Guidelines
31
Pharmacy & Technologies
21
Women & Child Health
16
Capacity Building
9
Key Resources
4
Public Health
2
Les données COVID-19 anonymisées reçues des États Parties par l’intermédiaire de la plateforme de données COVID-19 resteront la propriété de l’État Partie contributeur et seront utilisées par l’OMS à des fins de vérification, d’évaluation et d’assistance conformément au RSI (...
User Guide.
This Laboratory Assessment Tool (LAT) is specifically designed to assess capacities of existing laboratories which have implemented or aim to implement SARS-CoV-2 testing. It addresses both core capacities of a laboratory and specificities related to SARS-CoV-2 testing. It is a focused...
Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVI...
Countries who have no testing capacity and national COVID-19 laboratories with limited experience on COVID-19 virus testing are encouraged to send the first five positives and the first ten negative COVID-19 samples to WHO reference laboratories providing confirmatory testing for COVID-19.
Updates ...
Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in their assay assessment...
Lignes directrices provisoires
17 janvier 2020
Le présent document a été rédigé en s’appuyant sur divers documents existants de l’OMS, y compris les lignes directrices de l’OMS relatives au dépistage en laboratoire du MERS-CoV (1-11). À mesure que de nouvelles informations seront r...
Algorithm for COVID-19 triage and referral
recommended
Efficient triage of patients with COVID-19 at all health facility levels (primary, secondary and tertiary) will help the national response planning and case management system cope with patient influx, direct necessary medical resources to efficiently support the critically ill and protect the safety...
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 addresses common concerns people living with HIV have rega...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
Given the current situation of the COVID-19 pandemic, countries are advised to continue adopting the TB diagnostic algorithms recommended by PAHO / WHO.
Despite the differences in the modes of transmission of TB and COVID-19, certain personal protection measures are relevant for both diseases. Rout...
O Centro Africano de Prevenção e Luta contra Doenças (CDC-África) está preocupado com a divulgação de informações incorrectas através de meios de comunicação tradicionais e sociais sobre a prevenção e o tratamento de nova doença de coronavírus (COVID-19).
The Africa Centres for Disease Control and Prevention (Africa CDC) is concerned about inaccurate information being distributed through traditional and social media regarding prevention and treatment of novel coronavirus disease (COVID-19).
Entretanto, à luz da possível introdução de um caso suspeito relacionado ao COVID-19 na Região das Américas, a Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS) recomenda que os Estados-membros garantam sua identificação oportuna, o envio de amostras a laborat...
Orientação provisória 17 de março de 2020
Esta orientação rápida destina-se a profissionais de saúde pública e de prevenção e controle de infecção (PCI), gestores e profissionais de saúde, ao abordar questões relacionadas ao atendimento domiciliar de pacientes com suspeita de infecç...
Brindar recomendaciones sobre la atención inicial de personas con enfermedad respiratoria aguda (ERA) en el contexto de la infección por coronavirus (COVID-19) en establecimientos de salud basado en flujograma de toma de decisiones. Estas recomendaciones son preliminares y están sujetas a revisi...
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...
O objetivo deste documento é fornecer orientações provisórias de biossegurança laboratorial para testes com amostras clínicas de pacientes que atendam à definição de casos do novo patógeno identificado em Wuhan, China, ou seja, a doença do coronavírus 2019 (COVID-19). A OMS revisará ess...
